Patent · US Expired

2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors

US6951889B2 · kind B2 · utility

9Cited by

5References

217Claims

0Family size

Assignee

Pharmacia Corporation · SE

Inventors

Donald W. Hansen, Jr. · Chicago, US
Ronald Keith Webber · Holden, US
Barnett S. Pitzele · Skokie, US
James A. Sikorski · Des Peres, US
Mark A. Massa · Ballwin, US
Timothy J. Hagen · Gurnee, US
Margaret L. Grapperhaus · Glen Carbon, US
Lijuan Wang · Wildwood, US
Arija A. Bergmanis · Plainfield, US
Steven W. Kramer · Des Plaines, US
E. Ann Hallinan · Evanston, US

Key dates

Filing date	Sep 15, 2001
Grant date	Oct 4, 2005
Priority date	—
Expiry date	Jan 20, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/09
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives and their use in therapy, in particular their use as nitric oxide synthase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.